We identified human carcinomas where high level of SIK mRNA expression correlated with worse disease outcome, in other words, lower chance of survival after progressed disease stage, as exemplified by breast, gastric and ovarian carcinomas (Figure 6C). The gene discussed is SIK1; the disease is carcinoma.